Insider Activity of HILLHOUSE INVESTMENT MANAGEMENT, LTD.
According to the SEC Form 4 filings, HILLHOUSE INVESTMENT MANAGEMENT, LTD., being in a position of
- 10 percent owner at ArriVent BioPharma, Inc. Common Stock,оver the last 12 months, has bought 0 shares, and sold 555555 shares for $12.98M,over all time since 2024-01-30, has bought 555555 shares for $10M, and sold 555555 shares for $12.98M.
Biography of HILLHOUSE INVESTMENT MANAGEMENT, LTD.
No biography is available at this moment.